dronabinol has been researched along with Brain Ischemia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jouanjus, E; Wolff, V | 1 |
| Gai, N; Leker, RR; Mechoulam, R; Ovadia, H | 1 |
| Lavie, G; Leker, RR; Ovadia, H; Teichner, A | 1 |
| Braida, D; Capurro, V; Sala, M; Zani, A | 1 |
| Aral, E; Arslan, OC; Durmaz, R; Kanbak, G; Kartkaya, K; Ozden, H; Uzuner, K | 1 |
| Biegon, A; Joseph, AB | 1 |
| Belayev, L; Busto, R; Ginsberg, MD; Zhao, W | 1 |
| Bar-Joseph, A; Belayev, L; Berkovich, Y; Biegon, A; Vered, M | 1 |
| Belayev, L; Busto, R; Ginsberg, MD; Watson, BD | 1 |
| Lavie, G; Leker, RR; Ovadia, H; Shohami, E; Teichner, A | 1 |
| Perron, RR; Sutherland, GR; Tyson, RL | 1 |
2 review(s) available for dronabinol and Brain Ischemia
| Article | Year |
|---|---|
Strokes are possible complications of cannabinoids use.
Topics: Adolescent; Adult; Brain; Brain Ischemia; Cannabidiol; Cannabinoids; Cannabis; Cohort Studies; Dronabinol; Drug Combinations; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Risk Factors; Stroke; Vasoconstriction; Young Adult | 2017 |
Development of HU-211 as a neuroprotectant for ischemic brain damage.
Topics: Animals; Brain Injuries; Brain Ischemia; Dronabinol; Excitatory Amino Acid Antagonists; Gerbillinae; Head Injuries, Closed; Neuroprotective Agents; Rats; Receptors, N-Methyl-D-Aspartate | 1995 |
9 other study(ies) available for dronabinol and Brain Ischemia
| Article | Year |
|---|---|
Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210.
Topics: Animals; Blood Pressure; Body Temperature; Brain Infarction; Brain Ischemia; Disability Evaluation; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Heart Rate; Hypothermia, Induced; Motor Activity; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rewarming; Treatment Outcome | 2003 |
Combination of dexanabinol and tempol in focal cerebral ischemia: is there a ceiling effect?
Topics: Animals; Behavior, Animal; Body Weight; Brain Ischemia; Cyclic N-Oxides; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; Male; Motor Activity; Neuroprotective Agents; Rats; Rats, Inbred SHR; Recovery of Function; Spin Labels; Treatment Outcome | 2003 |
Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors.
Topics: Animals; Arachidonic Acids; Body Temperature; Brain Ischemia; Carotid Artery, Common; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Electroencephalography; Gerbillinae; Male; Memory; Motor Activity; Receptor, Cannabinoid, CB1; Receptors, Opioid; Time Factors; TRPV Cation Channels | 2007 |
The protective effect of dexanabinol (HU-211) on nitric oxide and cysteine protease-mediated neuronal death in focal cerebral ischemia.
Topics: Animals; Brain Ischemia; Cathepsin B; Cathepsin L; Cathepsins; Cell Death; Cerebral Cortex; Cysteine Endopeptidases; Dronabinol; Humans; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Neurons; Neuroprotective Agents; Nitrates; Nitric Oxide; Nitrites; Rats; Rats, Sprague-Dawley | 2008 |
HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat.
Topics: Animals; Brain Ischemia; Dronabinol; Male; N-Methylaspartate; Neuroprotective Agents; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1995 |
Anti-ischemia activity of HU-211, a non-psychotropic synthetic cannabinoid.
Topics: Animals; Brain; Brain Edema; Brain Ischemia; Dronabinol; Gerbillinae; Hippocampus; Injections, Intravenous; Ischemic Attack, Transient; Male; Nerve Degeneration; Neurologic Examination; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1994 |
Post-ischemic administration of HU-211, a novel non-competitive NMDA antagonist, protects against blood-brain barrier disruption in photochemical cortical infarction in rats: a quantitative study.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Cerebral Infarction; Dronabinol; Male; Neuroprotective Agents; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Time Factors | 1995 |
Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia.
Topics: Animals; Body Weight; Brain Ischemia; Cardiovascular Physiological Phenomena; Cerebral Cortex; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Encephalitis; Free Radicals; Infarction, Middle Cerebral Artery; Male; Movement Disorders; Nerve Degeneration; Neurons; Neuroprotective Agents; Rats; Rats, Inbred SHR; Tetrazolium Salts | 2001 |
Delta9 -tetrahydrocannabinol increases brain temperature and inverts circadian rhythms.
Topics: Animals; Body Temperature; Brain Ischemia; Circadian Rhythm; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Energy Metabolism; Hypothermia; Male; Neuroprotective Agents; Psychotropic Drugs; Rats; Rats, Sprague-Dawley | 2001 |